Establishing the Diagnosis Standard and Analysis the Risk Factors of POI in Chinese Women
NCT ID: NCT03518918
Last Updated: 2018-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50000 participants
OBSERVATIONAL
2016-09-01
2021-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Establishing of an Early Warming System of Premature Ovarian Insufficiency
NCT03518944
Clinical Application of Serum Anti-Müllerian Hormone (AMH) Measurements
NCT05858307
Primary Ovarian Insufficient Patients
NCT03989154
A Multicenter Observational Study on the Development and Health Effects of Premature Ovarian Insufficiency
NCT06067529
Precise Stratification of Genetic Risk of Ovarian Function Impairment
NCT05665010
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The length of menstrual cycle longer than 35 days or shorter than/amenorrhea
* Serum FSH levels ≥10mIU/ml/ serum AMH levels ≤1.0pg/ml/ AFC ≤7, on at least two occasion \>4 weeks apart
Exclusion Criteria
* other causes of amenorrhea
12 Years
39 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Queen Mary Hospital, Hong Kong
OTHER
Southern Medical University, China
OTHER
The Third Affiliated Hospital of Southern Medical University
OTHER_GOV
Shenzhen Hospital of Southern Medical University
OTHER
Shen-Zhen City Maternity and Child Healthcare Hospital
OTHER
Guangdong Provincial Hospital of Traditional Chinese Medicine
OTHER
Nanfang Hospital, Southern Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shi-ling Chen, M.D, Ph.D
Role: STUDY_CHAIR
Nanfang Hospital, Southern Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center for Reproductive Medicine, Department of Gynecology and Obstetrics, Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NFEC-2016-141
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.